Glucose and lipids are essential to the body, but excess glucose or lipids lead to metabolic syndrome. ATP-binding cassette (ABC) proteins are involved in the homeostasis of glucose and lipid in that they regulate insulin secretion and remove excess cholesterol from the body. Sulfonylurea receptor (SUR) is a subunit of the ATP-sensitive potassium channels, which regulate insulin secretion from pancreatic -cells by sensing cellular metabolic levels. ABCG1 removes excess cholesterol from peripheral tissues and functions in reverse cholesterol transport to the liver. ABCG5 and ABCG8 suppress the absorption of cholesterol in the intestine and exclude cholesterol from the liver to the bile duct. ABCG1 and ABCG4, expressed in the central nervous system, play roles in lipid metabolism in the brain. These ABC proteins are targets of drugs and functional foods to cure and prevent diabetes, hyperlipidemia, and neurodegenerative diseases. In this review, recent knowledge of the physiological function and regulation of ABC proteins in the homeostasis of glucose and lipids is discussed.
Metabolic syndrome is a combination of obesity, diabetes, hyperlipidemia, and hypertension. The number of patients with metabolic syndrome is rapidly increasing, and this is a major problem in the field of epidemics worldwide, because it increases the risk of cardiovascular and cerebrovascular disease. Therefore, much attention has been paid to the molecular mechanisms of glucose and lipid homeostasis in the body. It has been found that ATP-binding cassette (ABC) proteins are involved in the homeostasis of glucose and lipids, including cholesterol.
ABC proteins, also known as ABC transporters, are superfamily membrane proteins consisting of two wellconserved nucleotide-binding folds (NBFs) in a functional unit. There are 48 or 49 ABC proteins in humans (Fig. 1) . 1) ABC proteins are subdivided into seven subfamilies (ABCA, ABCB, ABCC, ABCD, ABCF, and ABCG) based on their sequence homology. Sulfonylurea receptor (SUR), which belongs to the ABCC subfamily, plays important roles in the regulation of insulin secretion, and many ABC proteins, including members of ABCA and ABCG subfamilies, are involved in the regulation of the cholesterol level in the body.
Glucose is the most important energy source for the body, but it becomes harmful when the concentration is out of control. High blood glucose leads to diabetes mellitus, whereas low blood glucose leads to hypoglycemia. Insulin secretion from the pancreas plays a major role in the regulation of blood glucose levels. Elevation of the blood glucose concentration results in increased glucose uptake and metabolism by pancreatic -cells, which leads to insulin secretion from the -cells. Insulin, a peptide hormone, binds to insulin receptor and activates the signal transduction pathways downstream, which stimulates carbohydrate utilization and protein synthesis.
Cholesterol plays important roles in our body as a component of cellular membranes and a source of steroid hormones. There are delicate mechanisms to maintain the cholesterol level in the body. However, the increasing intake of a high-fat diet creates a problem of excess cholesterol in body, which leads to hyperlipidemia, a risk factor for atherosclerosis. About 1,200-1,700 mg of cholesterol, 300-500 mg of which are of dietary origin and the rest in bile, enter the lumen of the small intestine per day in the average adult.
2) About 50% of the cholesterol is absorbed from the intestine, and the absorbed cholesterol is delivered to the liver in the form of chylomicrons. The cholesterol in the chylomicrons is endocytosed by low density lipoprotein (LDL)-receptor and LDL receptor-related protein in the hepatocytes. Cholesterol is delivered to peripheral tissues from the liver in the form of LDL or VLDL. The cholesterol needed in the peripheral cells is synthesized in the cells or taken from LDL via LDL receptor. Because peripheral cells cannot metabolize unnecessary cholesterol, excess cholesterol must be disposed of. It is excreted from the cells and delivered back to the liver as high density lipoprotein (HDL), whose pathway is called the reverse transport of cholesterol. The cholesterol in HDL is imported into the hepatocytes by SR-B1. Excess cholesterol in the body is excreted directly to the bile duct or is changed to bile acid, which is also excreted to the bile duct. The cholesterol in the bile is excreted from the body as feces or reabsorbed in the intestine.
Twenty-five percent of body cholesterol is in the brain, although the mass of the brain is only 3% of the body.
3) The cholesterol level in the central nervous system (CNS) is regulated independently from that in the peripheral tissues. The cholesterol in the neurons is provided by glial cells, mostly astroglia. ApoE-containing lipoproteins (LpE, HDL-like particles) are secreted from the astrocytes, and the cholesterol in the LpE stimulates synaptic efficacy. 4) In this review, the function and physiological significance of ABC proteins in glucose and lipid homeostasis are described, focusing on ABCC and ABCG subfamily members, which are especially important in the regulation of ATP-sensitive potassium (K ATP ) channels and in cholesterol transport respectively.
I. ABC Proteins Involved in Glucose Homeostasis
K ATP channels are inwardly rectifying potassium channels that are inhibited by ATP and activated by MgADP. They link the metabolism of the cells to the membrane potential by sensing changes in the intracellular adenine nucleotide concentration. K ATP channels play important functional roles in numerous tissues, including pancreatic -cells, neurons, cardiac muscle, skeletal muscle, and smooth muscle. In the CNS, K ATP channels serve as glucose sensors in the glucoseresponsive neurons of the hypothalamus, which are essential for maintenance of the regulation of hypoglycemia-induced glucagon secretion.
5) The K ATP channels in substantia nigra reticulate neurons protect the brain from hypoxia-induced seizure propagation. 6 ) Cardiac K ATP channels protect the myocardium from ischemic injury, whereas vascular smooth muscle K ATP channels regulate vessel tone. 7) The physiological role of K ATP channels is best understood in pancreatic -cells, where they link changes in the blood glucose concentration to insulin secretion (Fig. 2) . Under normal conditions, the K ATP channels are open and set the -cell resting membrane potential. Elevation of the blood glucose concentration results in increased glucose uptake and metabolism by -cells. This closes the K ATP channels, producing a membrane depolarization that activates voltagedependent calcium channels (VDCCs) and thereby causes a rise in the intracellular calcium concentration which stimulates insulin release.
SUR
The K ATP channels form a hetero-octameric complex of four Kir6.x and four SUR subunits (Fig. 1 ). Kir6.x (Kir6.1 or Kir6.2) belongs to the family of inwardly rectifying K þ channels, and assembles in tetramers to form the channel. The binding of ATP to the intracellular domains of this subunit produces channel inhibition. SUR is a member of the ABCC subfamily, and has three subtypes, SUR1 (ABCC8), SUR2A (ABCC9A), and SUR2B (ABCC9B), where SUR2A and SUR2B are splicing variants. [8] [9] [10] SUR has two NBFs and three transmembrane domains (TMDs), arranged in 5, 6, and 6 transmembrane -helices (Fig. 1). 11) Each NBF contains highly conserved motifs: the Walker A motif, the Walker B motif, and the ABC signature motif. Interaction of Mg-nucleotides with these NBFs mediates activation of the K ATP channels. SUR also binds therapeutic drugs, such as sulfonylureas, which are drugs widely used for type-2 diabetes that inhibit K ATP channel activity, and the K ATP channel openers, which stimulate channel activity. Variation in the subunit composition of the K ATP channels accounts for the different metabolic and drug sensitivities of the K ATP channels in different cells. In most tissues, Kir6.2 serves as the pore-forming subunit, but it associates with different SUR subunits, for example, SUR1 in the pancreas and the brain, SUR2A in the heart and skeletal muscle, and SUR2B in a variety of tissues, including the brain and the smooth muscle. In some smooth muscles, the K ATP channels are composed of Kir6.1 and SUR2B. Many ABC proteins, including ABCA1 and ABCB4, consist of two TMDs and two NBFs. TMDs are highly hydrophobic, integral transmembrane domains, each of which spans the membrane 6 times via -helices. NBFs are highly conserved among ABC proteins, each of which contains a conserved Walker A motif, an ABC signature (LSGGQ motif), and a Walker B motif, which are essential for the binding and hydrolysis of ATP. Members of the ABCG subfamily are half-type ABC proteins, consisting of one NBF and one TMD. ABCG subfamily proteins function in the form of a homodimer or a heterodimer. SUR has extra TMD at its N-terminal and 17 transmembrane -helices. K ATP channels consist of SUR and Kir subunits, and function in the form of a heterooctamer.
Nucleotide binding properties of SUR
Mutations within the Walker A and Walker B motifs of both NBFs of SUR1 abolished the activation of K ATP channels by MgADP, [12] [13] [14] suggesting that MgADP stimulates K ATP channel activity via the SUR subunit. Gribble et al. also reported that MgATP activated the SUR1/Kir6.2 channels by interaction with the NBFs of SUR1. 15) Therefore, both MgATP and MgADP can stimulate K ATP channel activity via the NBFs of the SUR subunit.
To elucidate the molecular basis of channel regulation by SUR, the nucleotide-binding properties of two NBFs of SUR1 were examined using the photoaffinity analog 8-azido-[
32 P]ATP. 16) Photaffinity labeling experiments have suggested that SUR1 has two ATP binding sites, a high affinity site, and the other a low affinity site. Mutations of the Walker A or the Walker B motif of NBF1 abolished the high-affinity 8-azido-ATP labeling of SUR1, whereas equivalent mutations in NBF2 did not affect it. This indicates that NBF1 of SUR1 is the highaffinity 8-azido-ATP binding site.
To examine the nucleotide binding of two NBFs in more detail, we separated the two NBFs of SUR, photoaffinity labeled with 8-azido-ATP, by mild digestion with trypsin. 17, 18) The ATP binding properties of the tryptic fragments indicated that NBF1 of SUR binds 8-azido-ATP in a Mg 2þ -independent manner, and that NBF2 binds 8-azido-ATP in a Mg 2þ -dependent manner, suggesting that NBF2 is responsible for channel activation by MgADP, because K ATP channels were activated by ADP only in the presence of Mg 2þ .
13)
The NBF2 of SUR was photoaffinity-labeled with 8-azido-[-32 P]ATP but not with 8-azido-[-32 P]ATP at 37 C, whereas NBF1 was photoaffinity-labeled with both 8-azido-[- 32 P]ATP and 8-azido-[-32 P]ATP. 17, 18) It has been found that SUR2A/Kir6.2 channels, immunoprecipitated from cardiac cell membranes, have ATPase activity and that purified NBF2 of SUR2 has higher ATPase activity than purified NBF1. 19, 20) This suggests that NBF2 has ATPase activity and bound MgATP is hydrolyzed to MgADP, and that NBF1 has little, if any activity.
Cooperative nucleotide binding of SUR
High-affinity and stable 8-azido-ATP binding to NBF1 of SUR1 made it possible to investigate cooperative interaction between the two NBFs.
21) The addition of MgADP or MgATP markedly stabilized prebound 8-azido-ATP at NBF1, whereas the slowly-hydrolysable ATP analog, ATP-S, did not. Mutations in the Walker A and in the Walker B motif of NBF2 had almost no effect on 8-azido-ATP binding itself, but abolished the ability of MgADP to stabilize prebound 8-azido-ATP. These results suggest that MgADP, either by binding directly to NBF2 or by hydrolysis of bound MgATP, induces a conformational change at NBF2 that results in stabilization of ATP binding at NBF1. Similar cooperativity was found for nucleotide binding to the two NBFs of SUR2A and SUR2B.
18) It has been reported that cooperative nucleotide binding is essential for K ATP channel opening, suggesting that cooperativity is functionally important. 22) 4. Nucleotide binding of disease-related mutants of SUR Altered function of K ATP channels is responsible for human diseases, because K ATP channels play important physiological roles. Overactivity of K ATP channels leads to diabetes, 23) whereas defects in the channel activity lead to persistent hyperinsulinemic hypoglycemia of infancy (PHHI). 24, 25) It has been reported that Kir6.2 polymorphism (E23K) reduces ATP sensitivity of K ATP channels and is associated with type-2 diabetes, [26] [27] [28] and that mutations in SUR1 enhance K ATP currents and cause neonatal diabetes. [29] [30] [31] Mutations of SUR2A, which alter the sensitivity of K ATP channels on nucleotides, have been identified to be responsible for dilated cardiomyopathy. 32) PHHI is a genetic disorder characterized by inappropriate insulin secretion despite severe hypoglycemia. 24, 25) Many missense mutations are found within the NBFs of SUR1. Several mutations have been reported to impair K ATP channel activity by reducing MgADP activation. 33, 34) A missense SUR1 mutation (R1420C) has been identified in Japanese patients with a mild form of PHHI. 35) Verkarre et al. also reported this At low glucose levels, the intracellular concentrations of ATP and ADP are low and high respectively. Under this condition, K ATP channels composed of SUR1 and Kir6.2 stay open to maintain membrane potential. At high blood glucose levels, the amount of glucose taken up by glucose transporter2 (GLUT2) increases. ATP, generated by glycolysis and the Krebs cycle, inhibits the activity of the K ATP channels. The consequent reduction in potassium efflux results in membrane depolarization and Ca 2þ influx through voltage-dependent calcium channels (VDCCs). The rise in intracellular Ca 2þ concentrations leads to the fusion of secretory granules containing insulin with the membrane and secretion of insulin into the circulation. mutation in a patient with focal adenomatous hyperplasia of the pancreatic islets.
36) The mutation decreases the expression of functional K ATP channels. We found that the mutation does not affect the affinity of NBF1 for nucleotides, but lowers the affinity of NBF2 for ATP and for ADP.
37) The R1420C mutation impairs cooperative nucleotide binding of the two NBFs, although it does not show direct effects on high-affinity 8-azido-ATP binding to NBF1. This suggests that some PHHI missense mutations of SUR1 that show a mild phenotype might directly or indirectly affect interaction with the nucleotides.
5. Differences between SUR1, SUR2A, and SUR2B as to nucleotide binding Pancreatic, cardiac, and vascular smooth muscle K ATP channels consisting of different subtypes of SUR differ in their responses to the cellular metabolic state. Under normal conditions, pancreatic -cell K ATP channels stay open to maintain the membrane potential, and close when elevation of the blood glucose concentration results in increased intracellular concentrations of ATP, triggering insulin secretion. 33, [38] [39] [40] On the other hand, cardiac muscle K ATP channels remain closed under normal conditions, and open when the intracellular ATP concentration decreases under ischemic stress, shortening the action potential duration and protect the myocardium from lethal injury. 7, 40, 41) Cardiac K ATP channels open to maintain cardiac cellular homeostasis in the adaptive reaction to stress. 42) We have found that several nucleotide binding properties are similar among all of the SUR subtypes, but the affinities of the NBFs of SUR for MgATP and MgADP differ among SUR subtypes.
18) The affinities of NBF1 of SUR1 for ATP and ADP, especially ATP, are significantly higher than those of SUR2A and SUR2B. The affinity of NBF1 of SUR2B for ATP is higher than that of SUR2A, and the affinities of NBF2 of SUR2B for ATP and ADP are significantly higher than those of SUR2A. These differences in the nucleotide binding affinities of SURs are perhaps related to differential regulation of the K ATP channels. Furthermore, the SUR2A mutations, identified in human dilated cardiomyopathy, underscored the essential role of the intrinsic ATP hydrolysis reaction in cardiac channel pore regulation. 32) Differences in the activities and properties of ATP hydrolysis by SUR1, SUR2A, and SUR2B might lead to different channel regulations of the SUR1/ Kir6.2, SUR2A/Kir6.2, or SUR2B/Kir6.1 channels and might account for their different physiological roles.
SUR as an ADP sensor
Based on studies analyzing nucleotide-binding properties, we proposed a model for the open and closed states of the K ATP channels (Fig. 3) . Because MgADP binding at NBF2 is essential for channel activation, we can assume that SUR binding MgADP at NBF2 activates the channel. The intracellular ATP concentration is thought to be several mM, more than 10 times higher than the intracellular ADP concentration. 12, [43] [44] [45] In low metabolic states, such as low blood glucose levels or ischemic conditions, the cellular ATP and ADP concentrations decrease and increase respectively in pancreatic -cells and cardiomyocytes. It is unlikely that MgADP directly replaces MgATP at NBF2 of SUR, because the cytosolic ADP concentration changes within the 100 mM range and is still about 10 times lower than the ATP concentration even in low metabolic states. 46) Therefore, an increase in the cytosolic MgADP concentration decelerates the ATP hydrolysis rate and increases the duration of MgADP binding at NBF2, which is the active state. In this way, SURs work as intracellular ADP sensors.
II. ABC Proteins Involved in Lipid Homeostasis
Recently, it has been found that many ABC proteins are involved in cholesterol homeostasis in that they transport lipid molecules, including cholesterol itself (Fig. 4) . ABCG1 and ABCA1 mediate the efflux of cholesterol from peripheral cells to HDL, and play important roles in the removal of excess cholesterol from cells. ABCG5 and ABCG8 excrete cholesterol and other sterols from hepatocytes to the bile duct, and ABCB11 (BSEP, SPGP) excretes bile acid. ABCB4 (MDR3) excretes phosphatidylcholine (PC), which forms bile with cholesterol and bile acid in the bile duct. ABCA3, expressed in alveolar type II cells, functions in lipid homeostasis in the lung, and mutations in ABCA3 lead to fetal surfactant deficiency of newborn. 47, 48) ABCG5 and ABCG8 restrain cholesterol absorption in the lumen of the intestine by excreting absorbed cholesterol. These transporters function in the removal of excess cholesterol from the body. Because impairment of cholesterol homeostasis leads to hyperlipidemia, a factor in metabolic syndrome, the relationship between the functions of ABC proteins and the cholesterol level in the body is an important issue.
ABCG proteins
ABCG subfamily proteins are half-type ABC proteins, consisting of an N-terminal cytosolic NBF and a C-terminal TMD that has six transmembrane -helices (Fig. 1) . There are five ABCG subfamily members in humans: ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. ABCG1 mediates the efflux of cholesterol, sphingomyelin (SM), and PC into HDL from cells. 49, 50) ABCG2 transports xenobiotics and confers on cancer cells multidrug-resistance against various anticancer drugs. 51) ABCG4, which shares 69% identity in the amino acids with ABCG1, mediates the efflux of cholesterol into HDL, like ABCG1. 49) ABCG5 and ABCG8 mediate the efflux of cholesterol, sitosterol, and campesterol. Because ABCG subfamily proteins are half-type transporters, they make a homodier or heterodimer to function. ABCG2 forms a homodimer and localizes to the plasma membrane, whereas ABCG1 and ABCG4 forms a homodimer or heterodimer. 50, [52] [53] [54] ABCG5 and ABCG8 form a heterodimer that localizes to the plasma membrane where they function. 55, 56) (i) ABCG1 Human ABCG1 cDNA was cloned as a gene homologous to white in Drosophila, a transporter of eye pigments. 57) Cross-linking and coimmunoprecipitation experiments suggested that ABCG1 forms a homodimer. 50, 58) Cserepes et al. found that a Walker A lysine mutant of ABCG4 inhibited the ATPase activity of ABCG1 in a dominant-negative fashion, and suggested that ABCG1 can heterodimerize with ABCG4. 54) It is thought that ABCG1 is involved in cholesterol transport, because it is induced upon the loading of macrophages with cholesterol via a pathway of nuclear hormone receptors, liver X receptor and retinoid X receptor. [59] [60] [61] ABCG1 is highly expressed in the lung, brain, and spleen, and in macrophages. Kennedy et al. reported that disruption of the Abcg1 gene in mice on a high-fat, high-cholesterol diet showed accumulation of lipids in hepatocytes and macrophages, whereas overexpression of ABCG1 protected murine tissues from lipid accumulation. 62) Furthermore, mice lacking ABCG1 showed severe age-dependent pulmonary lipidosis. 63) This suggests that ABCG1 plays a critical role in cellular cholesterol homeostasis in several tissues. Recent study indicates that ABCG1 also plays a key role in the downregulation of T-cell proliferation and activation. 64) Endogenous ABCG1 is reported to localize to the perinuclear region and, in some cases, to be distributed in the plasma membrane of macrophagederived foam cells. 60, 65) It has been reported that ABCG1 mediates the efflux of cholesterol from cells to HDL-2 or HDL-3, but not to lipid-poor apolipoprotein A-I (apoA-I), 49) and that ABCG1 redistributes cholesterol to cell-surface domains accessible for removal by HDL. 58) We have found that ABCG1 mediates the efflux not only of cholesterol but also of SM by analyzing phospholipid species secreted by ABCG1. 50) This suggests that ABCG1 is involved in lipid efflux from peripheral cells (Fig. 5) . ABCA1, a mutation of which is responsible for Tangier disease, is also involved in lipid efflux in peripheral cells such as ABCG1. [66] [67] [68] Patients with Tangier disease show an absence of plasma HDL, and develop hypersplenism or precocious coronary artery disease, indicating that ABCA1 is important to the generation of plasma HDL. ABCA1 mediates the efflux of cholesterol and PC, which are loaded onto apoA-I to form pre-HDL. 69) Two groups have reported that the pre-HDL functions as an acceptor for lipids effluxed by ABCG1, indicating that ABCA1 and ABCG1 coordinately remove excess cholesterol from cells. 70, 71) Hence upregulation of ABCG1 and ABCA1, by increasing the amounts of proteins or enhancing activities, is predicted to protect the body from athrosclerosis.
(ii) ABCG4 ABCG4 has been identified as a protein homologous to ABCG1. ABCG4 is expressed in the eye and brain, 72) and is expressed in the cerebral cortex and medulla of the mouse brain. 73) However, it is not clear what type of cells it is in which ABCG4 is expressed in the brain and eye. Tarr et al. reported that ABCG4 is expressed in neurons and astrocytes, 74) whereas Uehara et al. reported it is expressed in microglia. 75) Wang et al. reported that ABCG4, expressed in HEK293 cells, mediates the efflux of cholesterol to HDL. 49) Furthermore, it has been reported that ABCG4 and ABCA1 function sequentially to remove cellular cholesterol. 71) Therefore, it is likely that ABCG4 meditates cholesterol transport in vivo.
(iii) ABCG5 and ABCG8 Cholesterol and noncholesterol sterols, including sitosterol, are taken every day in the diet. Whereas 50-60% of dietary cholesterol is absorbed from the intestine, less than 5% of noncholesterol sterols are absorbed. ABCG5 and ABCG8 are expressed in the apical membrane of the small intestine and liver, 76) and mutations of ABCG5 or ABCG8 cause sitosterolemia, an autosomal recessive disorder characterized by an accumulation of plant sterols in the plasma. 77) Disruption of ABCG5 or ABCG8 in mice exhibited the phenotype of sitosterolemia: an accumulation of plant sterols in the plasma, and reduced cholesterol excretion into the bile duct from the liver. 78, 79) On the other hand, overexpression of ABCG5 and ABCG8 decreased the fractional absorption and increased the biliary secretion of cholesterol. [80] [81] [82] ABCG5 and ABCG8, expressed in cultured cells, mediated the efflux of sterols from the cells into bile salts added to the medium. 83, 84) These findings suggest that ABCG5 and ABCG8 are involved in control of the absorption of sterols from the intestine and in the excretion of sterols from the liver (Fig. 5) .
Hence, it is expected that some substances that upregulate the expression or activate the functions of ABCG5 and ABCG8 enhance cholesterol elimination from the body. Indeed, Ikeda et al. found that soy protein reduced the cholesterol level in serum and liver by increasing ABCG5 and ABCG8 in rats. 85) It has been reported that the heterodimers of ABCG5 and ABCG8 localize to the plasma membrane, whereas the homodimers of ABCG5 and of ABCG8 are retained in the endoplasmic reticulum. 55, 56) We have found that the cytoplasmic regions of ABCG5 and ABCG8 are involved in retention of the homodimers of ABCG5 and ABCG8.
86) The lectin-like chaperones calnexin and calreticulin interact with ABCG5 and ABCG8 and facilitate cell-surface expression of the ABCG5/ABCG8 heterodimer. 87, 88) Missense mutations, which cause sitosterolemia, prevent heterodimer formation or trafficking to the plasma membrane. 87) It is suggested that the heterodimer of ABCG5 and ABCG8 reaches the plasma membrane and mediates the efflux of cholesterol and sitosterol from the cells, whereas their homodimers do not function in cholesterol efflux. However, the physiological significance of this regulation of trafficking is not yet clear.
Lipid raft and ABCG1
SM and cholesterol form ordered microdomains (raft domains, detergent-resistant membranes) in the plasma membrane. It was not clear whether ABCG1 mediates the efflux of cholesterol from the raft domains or the non-raft domains. Because it was assumed that SM influences membrane dynamics, the effect of changes in the SM content of the plasma membrane was examined. We investigated the effects of a reduction in SM without the effects of ceramide accumulation using a Chinese hamster ovary mutant cell line, LY-A, in which ceramide transfer is impaired due to a missense mutation of the ceramide transfer protein CERT. 89, 90) When LY-A cells were cultured in a sphingolipid-deficient medium, the SM content of LY-A cells was about 65% of that of the LY-A/CERT cells, stable transformants of LY-A with human CERT cDNA. Under these conditions, the content of cholesterol in the non-raft domains increased due to disruption of the raft domains. ABCG1 and ABCG4 form a homodimer or a heterodimer and localize to the raft domains of plasma membranes. ABCG1 mediates the efflux of cholesterol and SM to HDL in peripheral cells, whereas ABCG4 mediates the efflux of cholesterol. ABCG1 and the raft domains regulate each other. ABCG1, expressed in the astrocytes, is involved in the formation of LpE from apoE. ABCG1 and ABCG4, expressed in the neurons, affect the formation of A by modulating the raft structure. The ABCG5/ABCG8 heterodimer mediates the efflux of sterols, including cholesterol and sitosterol.
When ABCG1 was exogenously expressed in LY-A and LY-A/CERT cells, an efflux of cholesterol and SM was hardly observed in the LY-A cells. 91) When CERT was overexpressed and intracellular SM content was increased in Chinese hamster ovary cells, the efflux of cholesterol and SM to HDL increased by over 20%. These results suggest that lipid efflux by ABCG1 decreases when raft-cholesterol decreases and nonraftchoelsterol increases, and that lipid efflux increases when raft-cholesterol increases and nonraft-cholesterol decreases. ABCG1 was not solubilized by TritonX-100, suggesting that ABCG1 localizes to the raft domains (Matsuo, unpublished results) . This might explain the lipid efflux by ABCG1 in response to the cellular content of SM, and suggests that ABCG1 transports cholesterol from the raft domains. Furthermore, it suggests that ABCG1 mediates the efflux of SM, which is rich in raft domains (Fig. 5) .
Whereas the raft structure influences the function of ABCG1, the function of ABCG1 changes the raft structure by reorganizing lipids in the plasma membrane. It has been reported that expression of ABCG1 increases the cholesterol accessible to cholesterol oxidase because of destruction of the raft strucutre. 58, 92) These findings suggest that ABCG1 and membrane lipids regulate each other (Fig. 5) . Because the lipid raft is a platform of signal transduction and substrate transport, expression of ABCG1 can affect signaling and transport on the lipid raft by changing the raft structure.
Functions of ABCG1 and ABCG4 in brain
The cholesterol level in the brain is regulated independently by peripheral systems, because cholesterol cannot cross freely between the cerebrospinal fluid and the blood due to the presence of the blood-brain barrier. Cholesterol in the CNS is mainly supplied by synthesis, and excess cholesterol is converted to 24-hydroxycholesterol by CYP46A1. Because 24-hydroxycholesterol can cross the blood-brain barrier, 24-hydroxycholesterol is delivered to the liver, where it is metabolized. Although brain has only 3% of body mass, it contains 25% of whole body cholesterol. Cholesterol is abundant in myelin (oligodendrocyte) in the CNS, but neurons and other glial cells also contain it. Cholesterol and apoE are synthesized in astrocytes and LpE is formed, although it is not clear whether the lipidation of apoE occurs inside the cell or after secretion of apoE. LpE binds to LDL-receptor related family protein on neurons and then is endocytosed. The cholesterol in LpE is used as a component of cellular membranes or to support synaptogenesis. 4) Because ABCG1 is expressed in the astrocytes, it is predicted to be involved in the formation of LpE (Fig. 5) . In fact, ABCG1 mediates the efflux of cholesterol to apoE-PC liposomes, 93, 94) and functions in the formation of LpE. 95) Because ABCG1 and ABCG4 are also expressed in neurons, they may mediate the efflux of excess cholesterol from the neurons, though most of the excess cholesterol in the neurons is excreted after conversion to oxysterols such as 24-hydroxycholesterol. The absence of either ABCG1 or ABCG4 in mice does not affect the cholesterol level in the brain. 96 ) Surprisingly, desmosterol and lathosterol levels in brain were increased in Abcg1-/-and Abcg4-/-mice respectively. 96) 97) However, the physiological significance of ABCG1 and ABCG4 in the brain is not fully understood.
There are three major alleles in human apoE: apoE2, apoE3, and apoE4. ApoE4 is a strong risk factor for Alzheimer's disease, whereas apoE2 is associated with lower risk for the disease. 98) Furthermore, because administration of statin reduces the prevalence of Alzheimer's disease, 99) much attention has been paid to the relationships between cholesterol level in the CNS and neurodegenerative disease. Amyloid (A), one of the factors in Alzheimer's disease, is produced from amyloid precursor protein by -secretase and -secretase, which function in raft domains. 100) Furthermore, aggregation of A occurs in raft domains. 101) Excess cholesterol in the neurons enhances the crisis of Alzheimer's disease, and ABCG1 might suppress it by regulation of the raft domains. It has been reported that overexpression of ABCG1 suppressed the production of A. 93) A conflicting report states that ABCG1 enhances the expression level of APP, which leads to increased production of A. 102) Further studies are necessary to understand the roles of ABCG1 and ABCG4 in the pathology of Alzheimer's disease.
III. Perspectives
It is important to understand the molecular mechanisms of glucose and lipid homeostasis in the body, because impairment of the homeostasis system leads to metabolic syndrome. ABC proteins are key molecules in the maintenance of glucose and cholesterol levels. Because SUR regulates insulin secretion, it can be the target of a new drug for diabetes. Studies of the mechanisms of K ATP channel regulation by SUR might lead to the development of drugs for neonatal diabetes and PHHI. However, it is still unclear how SUR drives the opening of the Kir6.2 channels and how drugbinding to SUR modulates K ATP channel gating. Further study to determine mechanical and structural properties is required.
Because many ABC proteins function in the removal of excess lipids from cells and the body, we can expect that stimulation of function of ABC proteins can protect humans from hyperlipidemia. Therefore, molecules and chemicals that stimulate the expression and function of ABC proteins are candidates for drugs to cure or protect from hyperlipidemeia. However, we still do not know whether ABC proteins interact with and transport cholesterol directly, or change the lipid environment of membranes by redistributing lipid molecules, facilitating the removal of cholesterol by lipid acceptor molecules. Further studies on molecular mechanisms by which ABC proteins work in lipid release should lead to improvements in a high-throughput screening system for compounds to modify the function of ABC proteins.
Although cholesterol is rich in the brain, the transport and metabolism of cholesterol in the CNS is not fully understood. Because several neurodegenerative diseases such as Alzheimer's disease are related to disturbances of lipid metabolism in the CNS, it is important to study the function of ABC proteins in the CNS.
